Patents-Review.com
🔗 Permalink
Assignee profile:

Morphic Therapeutic, Inc.

City:

Waltham, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2024-11-14

Patent Grants:

16

Last grant date:

2025-11-04

Top Inventors for applications by Morphic Therapeutic, Inc.

These are the the leading inventors for applications assigned to Morphic Therapeutic, Inc.:

Recent patent applications by Morphic Therapeutic, Inc.

Morphic Therapeutic, Inc. based in Waltham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-11-14 ✅ Patent 12,459,942 granted on 2025-11-04
US20240376095A1
Chemistry; metallurgy

INHIBITING (ALPHA-V)(BETA-6) INTEGRIN

 #2 | 2024-10-03 ✅ Patent 12,415,796 granted on 2025-09-16
US20240327378A1
Chemistry; metallurgy

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

 #3 | 2024-09-05 ✅ Patent 12,221,416 granted on 2025-02-11
US20240294475A1
Chemistry; metallurgy

Antagonists of human integrin α4β7

 #4 | 2024-05-30
US20240174632A1
Chemistry; metallurgy

INHIBITING HUMAN INTEGRIN (ALPHA-4) (BETA-7)

 #5 | 2024-04-11 ✅ Patent 12,145,935 granted on 2024-11-19
US20240116929A1
Chemistry; metallurgy

Inhibitors of (α-v)(β-6) integrin

 #6 | 2023-08-03 ✅ Patent 12,528,803 granted on 2026-01-20
US20230242524A1
Chemistry; metallurgy

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

 #7 | 2023-07-13 ✅ Patent 12,552,786 granted on 2026-02-17
US20230219947A1
Chemistry; metallurgy

INHIBITORS OF AV ß6 INTEGRIN

 #8 | 2022-06-28 ✅ Patent 11,370,773 granted on 2022-06-28
US17378282
Chemistry; metallurgy

Inhibiting human integrin (alpha-4) (beta-7)

 #9 | 2022-03-10 ✅ Patent 11,739,087 granted on 2023-08-29
US20220073511A1
Chemistry; metallurgy

Inhibiting (α-v)(β-6) integrin

 #10 | 2021-09-16 ✅ Patent 11,795,167 granted on 2023-10-24
US20210284640A1
Chemistry; metallurgy

Inhibitors of (α-v)(β-6) integrin

 #11 | 2021-09-09 ✅ Patent 11,827,621 granted on 2023-11-28
US20210276975A1
Chemistry; metallurgy

Inhibitors of (α-v)(β-6) integrin

 #12 | 2020-12-10 ✅ Patent 11,021,480 granted on 2021-06-01
US20200385384A1
Chemistry; metallurgy

Inhibiting (α-V)(β-6) integrin

 #13 | 2020-12-10 ✅ Patent 11,174,228 granted on 2021-11-16
US20200385352A1
Chemistry; metallurgy

Antagonists of human integrin (α4)(β7)

 #14 | 2020-05-21 ✅ Patent 11,046,669 granted on 2021-06-29
US20200157075A1
Chemistry; metallurgy

Inhibitors of (α-v)(β-6) integrin

 #15 | 2020-03-19 ✅ Patent 11,040,955 granted on 2021-06-22
US20200087299A1
Chemistry; metallurgy

Inhibitors of (alpha-v)(beta-6) integrin

 #16 | 2020-01-02 ✅ Patent 11,046,685 granted on 2021-06-29
US20200002334A1
Chemistry; metallurgy

Inhibitors of (α-v)(β-6) integrin

 #17 | 2019-10-17 ✅ Patent 10,759,756 granted on 2020-09-01
US20190315692A1
Chemistry; metallurgy

Antagonists of human integrin α4β7

Also check out Morphic Therapeutic, Inc.'s (Waltham, United States) applicant profile with 20 patent applications submitted.

AssigneeID:

577885 ⎘